U.S. regulators add to the pressure on a struggling blood-testing startup.
As the outbreak spreads, affected countries may look toward a technological solution.
They spin in their cages and don’t interact. The scientists who created autistic monkeys say they’ll now try to cure them.
The brains that come through Ann McKee’s lab don’t lie. But they are only the beginning of the story about head trauma and its role in neurodegenerative disease.
Eric Lander of the Broad Institute writes a history of a gene-editing technique that may be seen as partial to one side of a patent dispute.
Mosquitoes that have been genetically modified to cause population crashes in the wild could be a potent tool against a host of troublesome diseases.
Relatively new discoveries about of the role of the microbiome in human health have sparked a race to develop new therapies based on microbes.
A joint venture between Bayer and CRISPR Therapeutics is the latest effort to make CRISPR drugs that could target and modify cells inside the body.
A “patent interference” proceeding will determine who controls foundational patents on gene editing.
The disorder known as trisomy 21 is untreatable. Or is it? Some families think an antidepressant could help.